First Personal Financial Services Exelixis, Inc. Transaction History

First Personal Financial Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$17.68 - $22.65 $7,602 - $9,739	-430 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$18.93 - $24.75 $2,290 - $2,994	121 Added 39.16%	430 $9,000
Q1 2019 Apr 22, 2019	BUY	$19.6 - $24.76 $1,254 - $1,584	64 Added 26.12%	309 $7,000
Q4 2018 Jan 30, 2019	SELL	$13.65 - $21.8 $68 - $109	-5 Reduced 2.0%	245 $5,000
Q2 2018 Aug 07, 2018	BUY	$18.56 - $22.45 $4,640 - $5,612	250 New	250 $5,000

460

246M

1.7M

1.02M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.